Browsing Study Simulations

Displaying study simulation 201 - 225 of 579 in total
GWAS-ROCS ID Condition/Phenotype | GWAS Central ID PubMed IDSNPs (p-value)Heritability AUROC ROC Plot
GR00197Dupuytren's disease | HGVRS209021732829
  • rs16879765 (6.0e-39)
  • rs6519955 (3.0e-33)
  • rs611744 (8.0e-15)
  • rs11672517 (7.0e-14)
  • rs2912522 (2.0e-13)
  • rs8124695 (8.0e-10)
  • rs7524102 (3.0e-09)
  • rs10809650 (6.0e-09)
  • rs4730775 (3.0e-08)
  • rs2179367 (3.0e-07)
  • rs4789939 (6.0e-07)
  • rs4932194 (8.0e-07)
  • (show allshow less)
0.0700.632487Gr00197
GR00198Dupuytren's disease | HGVRS493228886342
  • rs16879765 (3.0e-81)
  • rs2598107 (2.0e-44)
  • rs629535 (4.0e-40)
  • rs611744 (1.0e-32)
  • rs7291412 (2.0e-30)
  • rs2912522 (4.0e-29)
  • rs12342106 (4.0e-26)
  • rs38904 (4.0e-23)
  • rs1042704 (2.0e-19)
  • rs6102095 (2.0e-18)
  • rs394563 (1.0e-17)
  • rs11672517 (2.0e-17)
  • rs1032466 (2.0e-17)
  • rs6496519 (7.0e-17)
  • rs10276303 (1.0e-15)
  • rs10866846 (2.0e-15)
  • rs7524102 (3.0e-15)
  • rs7838717 (5.0e-14)
  • rs6016142 (1.0e-13)
  • rs2306022 (9.0e-11)
  • rs9951109 (1.0e-10)
  • rs17433710 (2.0e-10)
  • rs9525927 (2.0e-10)
  • rs1509406 (3.0e-10)
  • rs977987 (5.0e-10)
  • rs7071275 (1.0e-06)
  • rs4792901 (3.0e-06)
  • rs7866181 (5.0e-06)
  • (show allshow less)
0.1650.703099Gr00198
GR00199Early onset inflammatory bowel disease | HGVRS72619915574
  • rs10500264 (4.0e-10)
  • rs2412973 (2.0e-09)
  • rs8049439 (2.0e-09)
  • rs1250550 (6.0e-09)
0.0050.535948Gr00199
GR00200Early-onset obesity | HGVRS73119151714
  • rs1421085 (1.0e-28)
  • rs17782313 (5.0e-15)
  • rs1424233 (4.0e-13)
  • rs10508503 (2.0e-07)
  • rs1805081 (3.0e-07)
0.0250.579297Gr00200
GR00201End-stage renal disease in Type 1 diabetics (Women) | HGVRS370224029427
  • rs4972593 (4.0e-08)
0.0400.600398Gr00201
GR00202Endometrial cancer | HGVRS167421499250
  • rs4430796 (7.0e-10)
0.0020.520571Gr00202
GR00203Endometrial cancer | HGVRS501127135401
  • rs11263763 (7.0e-17)
  • rs2414098 (2.0e-13)
  • rs13328298 (1.0e-11)
  • rs11841589 (6.0e-10)
  • rs4733613 (8.0e-09)
  • rs2498796 (4.0e-08)
  • rs937213 (2.0e-07)
  • (show allshow less)
0.0060.538208Gr00203
GR00204Endometrial cancer | HGVRS501227135401
  • rs11263763 (3.0e-19)
  • rs2414098 (5.0e-13)
  • rs11841589 (5.0e-11)
  • rs13328298 (4.0e-10)
  • rs4733613 (3.0e-09)
  • rs937213 (2.0e-08)
  • rs2498796 (4.0e-08)
  • rs17232730 (4.0e-07)
  • (show allshow less)
0.0040.531305Gr00204
GR00205Endometriosis | HGVRS110020601957
  • rs10965235 (6.0e-12)
  • rs16826658 (2.0e-06)
0.0100.548766Gr00205
GR00206Endometriosis | HGVRS136721151130
  • rs12700667 (1.0e-09)
  • rs2738113 (3.0e-07)
  • rs12024204 (6.0e-06)
0.0040.532646Gr00206
GR00207Endometriosis | HGVRS269223104006
  • rs10859871 (5.0e-13)
  • rs7521902 (3.0e-11)
  • rs7739264 (4.0e-10)
  • rs1537377 (2.0e-09)
  • rs12700667 (4.0e-09)
  • rs13394619 (6.0e-09)
  • rs4141819 (9.0e-08)
  • (show allshow less)
0.0040.532533Gr00207
GR00208Enteric fever | HGVRS507525383971
  • rs7765379 (2.0e-13)
0.0000.500816Gr00208
GR00209Epilepsy | HGVRS257122949513
  • rs12059546 (4.0e-08)
  • rs39861 (3.0e-07)
0.0050.534961Gr00209
GR00210Epilepsy | HGVRS257222949513
  • rs10496964 (9.0e-09)
  • rs2717068 (4.0e-07)
  • rs10030601 (1.0e-06)
  • rs12720541 (9.0e-06)
0.0050.535098Gr00210
GR00211Epilepsy | HGVRS257322949513
  • rs13026414 (2.0e-09)
  • rs72823592 (9.0e-09)
  • rs771390 (6.0e-07)
  • rs11890028 (4.0e-06)
0.0070.540379Gr00211
GR00212Epilepsy | HGVRS582225087078
  • rs6732655 (9.0e-10)
  • rs28498976 (5.0e-09)
  • rs2947349 (1.0e-08)
  • rs1939012 (2.0e-08)
  • rs55670112 (6.0e-08)
  • rs12987787 (1.0e-07)
  • rs1044352 (2.0e-07)
  • rs535066 (2.0e-07)
  • rs111577701 (4.0e-07)
  • (show allshow less)
0.0060.539756Gr00212
GR00213Epithelial ovarian cancer | HGVRS563725134534
  • rs1413299 (2.0e-08)
  • rs1192691 (3.0e-08)
  • rs11175194 (1.0e-07)
  • rs633862 (9.0e-07)
  • rs6976769 (4.0e-06)
  • rs2500488 (4.0e-06)
  • (show allshow less)
0.0110.553318Gr00213
GR00214Epstein Barr virus nuclear antigen 1 IgG seropositivity | HGVRS421129868224
  • rs9272371 (4.0e-10)
0.0000.494505Gr00214
GR00215Esophageal cancer | HGVRS116020729852
  • rs3781264 (4.0e-09)
  • rs4072037 (4.0e-07)
0.0150.562091Gr00215
GR00216Esophageal cancer | HGVRS116120729852
  • rs3765524 (2.0e-09)
  • rs738722 (1.0e-08)
0.0080.543315Gr00216
GR00217Esophageal cancer | HGVRS160221642993
  • rs2074356 (2.0e-31)
  • rs2014300 (8.0e-22)
  • rs11066015 (7.0e-21)
  • rs2274223 (4.0e-20)
  • rs10052657 (2.0e-19)
  • rs11066280 (2.0e-15)
  • rs10484761 (7.0e-12)
  • rs8030672 (1.0e-11)
  • rs10058728 (5.0e-09)
  • rs9868873 (1.0e-07)
  • rs6772209 (3.0e-07)
  • (show allshow less)
0.0210.571934Gr00217
GR00218Esophageal cancer | HGVRS262322960999
  • rs4822983 (2.0e-22)
  • rs4785204 (2.0e-20)
  • rs6503659 (3.0e-16)
  • rs2239815 (4.0e-15)
  • rs2239612 (6.0e-14)
  • rs17761864 (2.0e-11)
  • rs2847281 (2.0e-11)
  • (show allshow less)
0.0060.539737Gr00218
GR00219Esophageal cancer | HGVRS262422960999
  • rs9288520 (4.0e-11)
  • rs17450420 (5.0e-08)
  • rs1042026 (3.0e-07)
  • rs3805322 (6.0e-07)
0.0080.544157Gr00219
GR00220Esophageal cancer | HGVRS355823644492
  • rs1050631 (4.0e-08)
0.0010.517236Gr00220
GR00221Esophageal cancer | HGVRS368224121790
  • rs11789015 (2.0e-07)
  • rs2687201 (6.0e-07)
  • rs10419226 (8.0e-07)
  • rs2342002 (9.0e-07)
  • rs6479527 (2.0e-06)
  • rs4610302 (4.0e-06)
  • rs2178146 (4.0e-06)
  • rs17172185 (5.0e-06)
  • (show allshow less)
0.0060.537109Gr00221
Displaying study simulation 201 - 225 of 579 in total